Article: Ciphergen Announces Cancer Research Collaboration With Johns Hopkins University.

FREMONT, Calif., Nov. 29 /PRNewswire/ --

Ciphergen Biosystems, Inc. (Nasdaq: CIPH) announced the start of a multi-year research collaboration with The Johns Hopkins University School of Medicine aimed at the discovery of novel protein biomarkers in the field of cancer. The focus of the collaboration will be the discovery and validation of diagnostic markers that improve tumor detection, tumor classification by type, invasiveness and stage, and tumor monitoring. The protein markers currently available to address these tasks are very limited in comparison with the scope of medical needs in oncology.

The research will be conducted by a group led by Daniel ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!